AbbVie Inc. (ABBV)
NYSE · Healthcare
AbbVie Inc. annual/quarterly long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- AbbVie Inc. long term debt for the quarter ending December 31, 2025 were 64.50B, a 3.50% decrease year-over-year.
- AbbVie Inc. long term debt for 2025 were 64.50B, a 3.50% decrease from 2024.
- AbbVie Inc. long term debt for 2024 were 66.84B, a 12.82% increase from 2023.
- AbbVie Inc. long term debt for 2023 were 59.24B, a 6.15% decrease from 2022.
- AbbVie Inc. long term debt for 2022 were 63.13B.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| AbbVie Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $64,503 |
| 2024 | $66,841 |
| 2023 | $59,245 |
| 2022 | $63,128 |
| 2021 | $75,962 |
| 2020 | $84,948 |
| 2019 | $67,233 |
| AbbVie Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $64,503 |
| 2024-12-31 | $66,841 |
| 2023-12-31 | $59,245 |
| 2022-12-31 | $63,128 |
| 2021-12-31 | $75,962 |
| 2020-12-31 | $84,948 |
| 2019-12-31 | $67,233 |
AbbVie Inc. Long Term Debt — FAQ
AbbVie Inc. (ABBV) long term debt over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABBV's long term debt history?
The chart and table above show AbbVie Inc.'s long term debt by year and by quarter, including the growth rate.